Research News
View articles by month and year
1–2 of 2 articles
-
Oral Bisphosphonates Don’t Seem to Reduce Recurrence Risk
Two studies found that two oral bisphosphonates didn't reduce recurrence risk for women diagnosed with early-stage breast cancer.
-
Long-Term Bisphosphonate Use Linked to Atypical Fracture Risk
Women who take bisphosphonates for more than 5 years have a higher risk of breaking a leg bone in an unusual spot.
1–2 of 2 articles
